Centers of excellence which will
offer cellular therapies and stem cell clinical trials will be set up by Fortis
Healthcare and TotipotentRX Cell Therapy Pvt. Ltd. at select Fortis
Hospitals across the country.
Stem cell clinical research
procedures relating to diabetes, cancer, cardiovascular disease and
neurological ischemia will be conducted at these centers. Processing of stem
cells before transplantation will also be done by TotipotentRX which will set
up cGMP laboratories in selected hospitals. The clinical trials will focus on regenerative
therapies, using stem cell sources like cord blood, bone marrow and adipose tissue.
A stem cell medical board which will
follow international and Indian Ethical guidelines will be created to oversee
the medical research program, ensure execution and monitor the progress. Training
will also be imparted by the board and at the same time they will create
awareness about the benefits of stem cell therapy across India.